M. Ridderheim et al., STEROID-PRODUCTION IN DIFFERENT PARTS OF MALIGNANT AND BENIGN OVARIAN-TUMORS INVITRO, Cancer research, 53(10), 1993, pp. 2309-2312
Pieces of ovaries and tumors from 45 patients (19 with malignant epith
elial tumors, 14 with benign epithelial tumors, and 12 with normal pos
tmenopausal ovaries) were incubated, and the release of steroid hormon
es from different parts of the tumors and from the contralateral ovari
es was measured. Tumor tissue (mainly tumor cells with a small number
of stromal cells), tumor base tissue (more stromal cells than tumor ce
lls), and control ovaries were preincubated in oxygenated 4-(2-hydroxy
ethyl)1-piperazineethanesulfonic acid-minimum essential medium buffer
at 37-degrees-C for 30 min followed by a 3-h incubation in fresh, oxyg
enated medium. Progesterone, androstenedione, testosterone, and estrad
iol were measured in the medium by radioimmunoassay at the end of the
incubation period. Malignant tumors released more progesterone and and
rostenedione than benign tumors or postmenopausal control ovaries. In
contrast, benign tumors released more testosterone than malignant tumo
rs or control ovaries. Release of estradiol was low and not significan
tly different among control ovaries and malignant and benign tumor tis
sue' Different parts of the tumors differed in steroid hormone release
. Tissue samples containing more tumor cells than stromal cells releas
ed more progesterone than those with predominantly stromal cells. Thus
, malignant tumors had an active steroid secretion. Progesterone was t
he main steroid released.